Selank vs Semax vs NA-Selank: Nootropic Peptide Comparison
Structural and analytical comparison of Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH, ~751 Da), Semax (Met-Glu-His-Phe-Pro-Gly-Pro-OH, ~813 Da), and NA-Selank (N-Acetyl Selank, ~793 Da) for research applications.

For laboratory research use only. Not for human consumption.
TL;DR: Selank is a heptapeptide derived from tuftsin with a Pro-Gly-Pro C-terminal extension (~751 Da). Semax is a heptapeptide analog of ACTH(4-10) with the same Pro-Gly-Pro extension (~813 Da). NA-Selank (N-Acetyl Selank) adds an acetyl group to Selank's N-terminus (~793 Da), enhancing metabolic stability. All three are research tools in neuroscience, but differ in parent peptide origin, receptor engagement, and analytical characteristics.
Last verified: April 2026 | Data accuracy confirmed by ChemVerify Editorial Team
Introduction: Three Russian-Developed Neuropeptides
Selank, Semax, and NA-Selank represent a family of synthetic heptapeptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Although all three share a common C-terminal Pro-Gly-Pro tripeptide extension designed to enhance enzymatic stability, they derive from fundamentally different parent molecules: Selank from the immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg), and Semax from the neuropeptide fragment ACTH(4-10) (Met-Glu-His-Phe-Pro-Gly-Pro). NA-Selank is a direct modification of Selank with an N-acetyl group [1][2][3].
These structural differences dictate divergent biological activities, receptor interactions, and degradation profiles. Researchers working with these compounds must understand their chemical distinctions for proper experimental design, analytical verification, and storage protocols.
Structural Origins: Tuftsin vs ACTH Derivatives
Tuftsin (Thr-Lys-Pro-Arg) is an immunostimulatory tetrapeptide naturally derived from the CH2 domain of IgG heavy chain (residues 289-292). It is released by the enzymatic action of tuftsin endocarboxypeptidase in the spleen. Selank extends this sequence with Pro-Gly-Pro at the C-terminus, creating the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH. This extension was rationally designed to reduce carboxypeptidase susceptibility while maintaining the bioactive N-terminal tuftsin pharmacophore [1][4].
ACTH(4-10) (Met-Glu-His-Phe-Pro-Gly-Pro) is the minimal nootropic fragment of adrenocorticotropic hormone, identified through structure-activity studies in the 1970s-1980s. Semax retains this exact sequence. The melanocortin pharmacophore (His-Phe-Arg-Trp, or in ACTH: Met-Glu-His-Phe) drives MC3R/MC4R receptor interactions. The Pro-Gly-Pro extension in Semax—identical to that in Selank—was added using the same stabilization rationale [2][5].
Molecular Architecture and Sequence Analysis
Selank: Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH. Molecular formula: C33H57N9O9. Molecular weight: ~751.87 Da. The molecule contains two proline residues in the parent sequence and two in the extension (Pro-3, Pro-5, Pro-7), creating a proline-rich peptide with limited conformational flexibility in those regions. The Lys-2 and Arg-4 residues confer a net positive charge at physiological pH [1].
Semax: Met-Glu-His-Phe-Pro-Gly-Pro-OH. Molecular formula: C37H51N7O10S. Molecular weight: ~813.00 Da. The N-terminal methionine introduces a thioether group susceptible to oxidation (Met-sulfoxide formation). The His-3 imidazole and Glu-2 carboxylate create a metal-chelating motif. The Phe-4 aromatic ring provides UV absorbance at 257 nm [2].
NA-Selank: Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH. Molecular formula: C35H59N9O10. Molecular weight: ~793.90 Da. The N-acetyl group caps the free alpha-amino group of Thr-1, adding 42.04 Da and eliminating the positive charge contribution from the N-terminus. This modification blocks aminopeptidase access to the peptide chain [3].
Physicochemical Properties and Solubility
All three peptides are freely soluble in water and aqueous buffers at pH 3-8. Selank and NA-Selank, rich in basic residues (Lys, Arg), have isoelectric points near pH 10-11, making them cationic at physiological pH. Semax, containing Glu and His, has a lower pI (~6.5-7.0) and a more balanced charge distribution. This difference affects their electrophoretic mobility, ion-exchange chromatography behavior, and potential for ionic adsorption onto negatively charged surfaces [1][2].
NA-Selank's acetyl group slightly increases hydrophobicity compared to unmodified Selank, resulting in marginally longer RP-HPLC retention times. Semax's phenylalanine and methionine residues provide greater overall hydrophobicity than either Selank variant, yielding the longest retention under standard reversed-phase conditions [3].
Stability and Degradation Pathways
Selank is primarily degraded by aminopeptidases cleaving the Thr-1 residue and carboxypeptidases attacking the C-terminal Pro. The Pro-Gly-Pro extension substantially slows C-terminal degradation (proline-containing sequences resist most carboxypeptidases). Lyophilized Selank at -20°C retains >95% purity for 18-24 months. Reconstituted solutions at pH 5-6 are stable for 2-3 weeks at 2-8°C [1][4].
Semax shares similar C-terminal stability (Pro-Gly-Pro) but is additionally vulnerable to Met-1 oxidation, forming Met(O)-Semax as the primary degradation product. This oxidation proceeds readily in the presence of dissolved oxygen, peroxides, or metal ions. Handling under nitrogen or argon atmosphere is recommended. Lyophilized Semax at -20°C is stable for 18 months; reconstituted solutions require antioxidant-free, degassed buffers [2][5].
NA-Selank benefits from dual protection: the N-acetyl group blocks aminopeptidase attack, and the Pro-Gly-Pro extension resists carboxypeptidases. This results in the highest metabolic stability of the three. The absence of Met eliminates oxidative degradation. Lyophilized NA-Selank at -20°C maintains >98% purity for >24 months [3].
N-Acetylation: Impact on NA-Selank Properties
The N-acetyl modification in NA-Selank serves three primary purposes in a research context. First, it blocks leucine aminopeptidase and other N-terminal exopeptidases, extending the peptide's half-life in biological matrices by 2-4 fold compared to unmodified Selank. Second, the acetyl group eliminates the N-terminal positive charge, slightly altering the compound's net charge and affecting interactions with anionic biological membranes. Third, the added mass (+42 Da) provides a convenient analytical marker for distinguishing NA-Selank from Selank in mixed samples [3][6].
The acetylation does not significantly alter the Pro-Gly-Pro C-terminal stability characteristics, as this is primarily governed by the steric properties of the proline residues. Researchers comparing Selank and NA-Selank can thus isolate the effect of N-terminal protection on biological activity in their experimental models.
Analytical Detection and Differentiation
RP-HPLC on C18 columns (gradient: 5-40% ACN/0.1% TFA over 25 min) resolves all three peptides. Elution order is typically: Selank < NA-Selank < Semax, reflecting increasing hydrophobicity. UV detection at 220 nm provides general peptide bond detection; Semax additionally absorbs at 257 nm (Phe) and 214 nm (Met thioether) [1][2][3].
Mass spectrometric confirmation: Selank [M+H]+ = 752.4; NA-Selank [M+H]+ = 794.4 (Δ = +42.0 from acetyl); Semax [M+H]+ = 814.0. The 42 Da mass shift between Selank and NA-Selank is diagnostic. Semax's distinct amino acid composition yields a completely different fragmentation pattern in MS/MS, with characteristic b-ions from Met-Glu-His-Phe [6][7].
Research Applications in Neuroscience
Selank is primarily investigated as an immunomodulatory neuropeptide in studies of anxiety-like behavior, interleukin expression, and enkephalinase activity. Its tuftsin backbone provides a link between immune modulation and neuronal signaling. Researchers use it in models studying the neuroimmune axis [1][4].
Semax is studied in the context of neurotrophic factor expression (BDNF, NGF), melanocortin receptor signaling, and neuroprotection models. Its ACTH(4-10) pharmacophore engages melanocortin receptors (MC3R, MC4R) involved in cognitive function. Semax is registered as a pharmaceutical in Russia, providing a substantial published research base [2][5].
NA-Selank is used when researchers require extended stability in biological matrices without altering the core tuftsin-derived pharmacophore. It is particularly useful in prolonged incubation studies, in vivo experiments requiring longer compound exposure, and when distinguishing metabolically intact peptide from degradation products is important [3][7].
Side-by-Side Comparison Table
| Parameter | Selank | Semax | NA-Selank |
|---|---|---|---|
| Parent peptide | Tuftsin (Thr-Lys-Pro-Arg) | ACTH(4-10) | Tuftsin (N-acetylated) |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Met-Glu-His-Phe-Pro-Gly-Pro | Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| MW | ~751 Da | ~813 Da | ~793 Da |
| Key vulnerability | Aminopeptidase (Thr-1) | Met-1 oxidation | Minimal (dual-protected) |
| pI (approx.) | ~10-11 | ~6.5-7.0 | ~10-11 |
| RP-HPLC retention | Shortest | Longest | Intermediate |
| MS [M+H]+ | 752.4 | 814.0 | 794.4 |
| UV marker | 220 nm only | 257 nm (Phe) | 220 nm only |
| Metabolic stability | Moderate | Moderate (Met-sensitive) | High |
Frequently Asked Questions
Q: What is the structural relationship between Selank and NA-Selank? A: NA-Selank is Selank with an N-acetyl group attached to the alpha-amino group of Thr-1. This adds 42.04 Da and blocks aminopeptidase degradation. The core heptapeptide sequence is otherwise identical.
Q: Why does Semax require more careful storage than Selank? A: Semax contains an N-terminal methionine residue whose thioether sulfur is readily oxidized to methionine sulfoxide. This requires handling under inert atmosphere and storage with desiccant. Selank and NA-Selank lack Met and are thus more oxidation-resistant.
Q: Can all three be distinguished in a single LC-MS run? A: Yes. They elute at different retention times on C18 RP-HPLC and have distinct m/z values (752.4, 814.0, 794.4). MS/MS fragmentation patterns are entirely different due to non-overlapping amino acid sequences.
For laboratory research use only. Not for human consumption. This article presents chemical and structural data for educational and research reference purposes.
Compounds Referenced in This Article
Explore detailed chemical profiles and research guides for compounds discussed in this article:
Further Reading on ChemVerify
- Read more: IGF-1 LR3 vs IGF-1 DES: Long-Acting vs Truncated Growth Factor → https://www.chemverify.com/learn/igf-1-lr3-vs-igf-1-des-comparison
- Read more: DSIP vs Selank for Sleep Research: Mechanism Comparison → https://www.chemverify.com/learn/dsip-vs-selank-sleep-research-comparison
- Read more: Semax vs. Selank: Nootropic Peptide Structural Comparison → https://www.chemverify.com/learn/semax-vs-selank
- Read more: Follistatin vs ACE-031: Myostatin Inhibitor Comparison → https://www.chemverify.com/learn/follistatin-vs-ace-031-myostatin-comparison
You Might Also Like
Continue Reading
DSIP vs Selank for Sleep Research: Mechanism Comparison
Scientific comparison of DSIP and Selank in sleep and anxiolytic research: delta-wave modulation, GABAergic mechanisms, peptidase resistance, and preclinical sleep architecture data.
Semax vs. Selank: Nootropic Peptide Structural Comparison
Structural comparison of Semax (ACTH 4-7 analog) and Selank (tuftsin analog) research peptides — amino acid sequences, molecular weight, stability, and analytical characterization.
IGF-1 LR3 vs IGF-1 DES: Long-Acting vs Truncated Growth Factor
Scientific comparison of IGF-1 LR3 (83aa, Arg3 substitution) and IGF-1 DES (67aa, truncated N-terminus): IGFBP binding, half-life, potency, and research applications.
Follistatin vs ACE-031: Myostatin Inhibitor Comparison
Scientific comparison of follistatin and ACE-031 (dalantercept) as myostatin inhibitors: binding mechanisms, activin receptor decoy strategies, preclinical muscle data, and research considerations.
